BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 23036600)

  • 1. Regeneration of the damaged central nervous system through reprogramming technology: basic concepts and potential application for cell replacement therapy.
    Matsui T; Akamatsu W; Nakamura M; Okano H
    Exp Neurol; 2014 Oct; 260():12-8. PubMed ID: 23036600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural stem cells differentiated from iPS cells spontaneously regain pluripotency.
    Choi HW; Kim JS; Choi S; Hong YJ; Kim MJ; Seo HG; Do JT
    Stem Cells; 2014 Oct; 32(10):2596-604. PubMed ID: 24898298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iPS cells: a source of cardiac regeneration.
    Yoshida Y; Yamanaka S
    J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of neural stem cells and progenitors: neuronal production and grafting applications.
    Bonner JF; Haas CJ; Fischer I
    Methods Mol Biol; 2013; 1078():65-88. PubMed ID: 23975822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of induced pluripotent stem cell technologies in spinal cord injury.
    Nagoshi N; Okano H
    J Neurochem; 2017 Jun; 141(6):848-860. PubMed ID: 28199003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of neural stem cells in regeneration of the central nervous system].
    Rybachuk OA; Pivneva TA
    Fiziol Zh (1994); 2013; 59(2):111-21. PubMed ID: 23828979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies toward CNS-regeneration using induced pluripotent stem cells.
    Okano H
    Genome Inform; 2009 Oct; 23(1):217-20. PubMed ID: 20180278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
    de Lázaro I; Yilmazer A; Kostarelos K
    J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin improves reprogramming efficiency and proliferation of bovine-induced pluripotent stem cells.
    Bai C; Li X; Gao Y; Yuan Z; Hu P; Wang H; Liu C; Guan W; Ma Y
    J Pineal Res; 2016 Sep; 61(2):154-67. PubMed ID: 27090494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
    Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
    Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and culture of porcine neural progenitor cells from embryos and pluripotent stem cells.
    Rasmussen MA; Hall VJ; Hyttel P
    Methods Mol Biol; 2013; 1074():185-98. PubMed ID: 23975814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
    Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
    Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural regeneration.
    Steward MM; Sridhar A; Meyer JS
    Curr Top Microbiol Immunol; 2013; 367():163-91. PubMed ID: 23292211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural Stem Cells Derived from Human-Induced Pluripotent Stem Cells and Their Use in Models of CNS Injury.
    Jendelova P; Sykova E; Erceg S
    Results Probl Cell Differ; 2018; 66():89-102. PubMed ID: 30209655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined transplantation of neural stem cells and olfactory ensheathing cells for the repair of spinal cord injuries.
    Ao Q; Wang AJ; Chen GQ; Wang SJ; Zuo HC; Zhang XF
    Med Hypotheses; 2007; 69(6):1234-7. PubMed ID: 17548168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
    López-González R; Velasco I
    Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.